Table 4.
Post-treatment SARS-CoV2 negative test rate (FAS/PPS), test rate difference, and Inter group comparison (FAS/PPS).
| SARS-CoV2 negative test | FAS | PPS | |||
|---|---|---|---|---|---|
| JHQG group | Placebo group | JHQG group | Placebo group | ||
| Post-treatment SARS-CoV2 negative test rate (FAS/PPS) | |||||
| No | 93 (62.00) | 86 (57.33) | 72 (55.81) | 64 (50.39) | |
| Yes | 57 (38.00) | 64 (42.67) | 57 (44.19) | 63 (49.61) | |
| SARS-CoV2 rate difference | Test method | FAS | PPS | ||
| Statistics | Statistics | ||||
| Post-treatment SARS-CoV2 negative test rate difference (FAS/PPS) | |||||
| JHQG group-Placebo group | Rate difference (95% CI) | −4.67 (−15.76, 6.42) | −5.42 (−17.63, 6.79) | ||
| SARS-CoV2 negative test rate | Model | FAS | PPS | ||
| Statistics | P -value | Statistics | P -value | ||
| Post-treatment SARS-CoV2 negative test rate inter-group comparison | |||||
| JHQG group vs. Placebo group | Chi-square test | 0.679 | 0.410 | 0.755 | 0.385 |